Facebook
X
LinkedIn
ForwardStratifying Risk in Breast Cancer: Navigating Prognosis and Personalized Treatment
Join leading oncologists Carlos Barrios, Lucia Del Mastro, and Rodrigo Sanchez-Bayona as they delve into the complexities of adjuvant therapy for early breast cancer. Discover the latest insights on risk stratification, the role of biomarkers and genomic assays, and innovative tools for personalized treatment. Learn how integrating clinical variables with cutting-edge technologies can revolutionize patient care and improve outcomes.
Target Audience
Healthcare Professionals
Learning Objectives
- Identify and interpret factors that influence breast cancer risk, including genetic markers, tumor grade, and lymph node involvement.
- Apply risk assessment tools and models to categorize patients into high, medium, or low risk in clinical practice.
- Recognize the different risk profiles of patients with EBC.
- Understand the prognostic and predictive value of clinical-pathological factors and risk evaluation tools.
This activity is supported by an educational grant from Eli Lilly.
Course summary
Dr. Carlos Barrios
Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, PUCRS
Director of LACOG (Grupo Latino Americano de Investigación Clínica en Oncologia – Latin American Clinical Oncology Research Group)
Oncologist of the Oncoclínicas Group in Porto Alegre
Professor Lucia Del Mastro
Director of the Clinical Oncology unit since 2021 and Coordinator of the Breast Unit since 2017 at Ospedale Policlinico San Martino, Genova Italy, Lucia Del Mastro is Full Professor of Oncology and Director of the Postgraduate School of Oncology at University of Genova, Italy
Dr. Rodrigo Sánchez-Bayona,MD PhD
Unidad de Cáncer de Mama y Ginecológico
Hospital 12 de Octubre
ESMO Young Oncologists Committee member